Medical Communications

Teva has announced that it is set to sell Allergan’s UK and Ireland-based generics business for $770 million.

Alnylam Pharmaceuticals’ shares lost close to half of their value as it was forced to end a trial of its …

Novartis has announced it is to shut down parts of its research operations in Switzerland and China and cutting 175 …

NICE rejected Merck’s Keytruda, a treatment for advanced non-small-cell lung cancer (NSCLC), on the basis that the drug was not …

The FDA has issued a warning to patients who are currently taking drugs to treat hepatitis C that they may …

Originally published in the October issue of Pharmafocus, Matt Fellows explores medical and pharmaceutical opinion of the divisive institute to …

AstraZeneca today announced that Professor David Goldstein will join the Company in the consultative role of Chief Adviser, Genomics to …

The latest issue of Pharmafocus is now available, and with it comes Advances in Oncology, our supplement featuring all the …

Coming towards the end of September, we’ve had some major developments in drug trials and bad news for some of …

A report commissioned by the European Union Intellectual Property Office has shown that a staggering amount of money, €10.2 billion, …

News broke on 29 September that Hanmi Pharma, South Korea’s leading drug maker, had signed a $910 million deal with …

The National Institute of Health and Care Excellence has issued final guidance rejecting Eli Lilly’s Portrazza (necitumumab) for the treatment …

GlaxoSmithKline PLC has named Brian McNamara the head of its consumer-health division. The new comes a week after the announcement …

AbbVie’s new Singapore based manufacturing plant is expected to be fully operational by late 2018. The plant is expected to …

The latest edition of Pharmafocus is available online now.